Yun Zhong

Stock Analyst at Wedbush

(3.96)
# 541
Out of 5,152 analysts
48
Total ratings
56.1%
Success rate
10.92%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Yun Zhong

MannKind
Mar 5, 2026
Maintains: Outperform
Price Target: $10$8
Current: $2.83
Upside: +182.69%
Ascendis Pharma
Feb 12, 2026
Maintains: Outperform
Price Target: $240$273
Current: $237.35
Upside: +15.02%
Sarepta Therapeutics
Jan 23, 2026
Maintains: Outperform
Price Target: $32$34
Current: $16.23
Upside: +109.49%
Rezolute
Jan 8, 2026
Maintains: Neutral
Price Target: $1$2
Current: $3.13
Upside: -36.10%
Wave Life Sciences
Dec 12, 2025
Maintains: Outperform
Price Target: $20$33
Current: $13.20
Upside: +150.00%
Keros Therapeutics
Nov 6, 2025
Maintains: Neutral
Price Target: $15$16
Current: $11.71
Upside: +36.64%
Opus Genetics
Oct 29, 2025
Initiates: Outperform
Price Target: $8
Current: $4.77
Upside: +67.71%
Protagonist Therapeutics
Oct 28, 2025
Maintains: Outperform
Price Target: $70$86
Current: $91.41
Upside: -5.92%
MoonLake Immunotherapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $80$18
Current: $18.02
Upside: -0.11%
Passage Bio
Aug 13, 2025
Maintains: Outperform
Price Target: $3$40
Current: $8.12
Upside: +392.61%
Initiates: Outperform
Price Target: $28
Current: $5.45
Upside: +413.76%
Maintains: Outperform
Price Target: $9$8
Current: $3.93
Upside: +103.56%
Initiates: Outperform
Price Target: $8
Current: $4.59
Upside: +74.29%
Reiterates: Outperform
Price Target: $32
Current: $4.64
Upside: +589.66%
Maintains: Buy
Price Target: $35$28
Current: $4.76
Upside: +488.24%
Downgrades: Neutral
Price Target: n/a
Current: $4.49
Upside: -
Maintains: Buy
Price Target: $14$16
Current: $14.33
Upside: +11.65%
Initiates: Buy
Price Target: $46
Current: $10.65
Upside: +331.92%
Initiates: Buy
Price Target: $10
Current: $0.39
Upside: +2,457.54%